Involvement of Angiopoietin-like 4 in Matrix Remodeling during Chondrogenic Differentiation of Mesenchymal Stem Cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Biological Chemistry Année : 2014

Involvement of Angiopoietin-like 4 in Matrix Remodeling during Chondrogenic Differentiation of Mesenchymal Stem Cells

Résumé

Background:Due to their ability to differentiate into chondrocytes, mesenchymal stem cells (MSCs) are candidates forcartilage repair. Results:During chondrogenic differentiation of MSCs, angiopoietin-like 4 (ANGPTL4) triggers degradation and reducedsynthesis of the cartilage matrix. Conclusion:ANGPTL4 promotes cartilage matrix remodeling. Significance:In the perspective of MSC-based cartilage engineering, inhibiting ANGPTL4 expression or action could help tostabilize cartilage formation. Mesenchymal stem cells (MSCs) are considered for cartilage engineering given their ability to differentiate into chondrocytes. Chondrogenic differentiation of MSCs is currently triggered by micromass culture in the presence of a member of the TGF-β superfamily. However, the main constituents of the cartilaginous matrix, aggrecan and type II collagen, are degraded at the end of the differentiation process through induction of matrix metallopeptidase (MMP)13. We hypothesized that MSCs undergoing chondrogenic differentiation produce an intermediate cytokine that triggers this matrix remodeling. Analysis of transcriptomic data identified angiopoietin-like 4 (ANGPTL4) as one of the most strongly up-regulated gene encoding a secreted factor during TGF-β-induced chondrogenesis. To gain insight into the role of ANGPTL4 during chondrogenesis, we used recombinant ANGPTL4 as well as a RNA interference approach. Addition of exogenous ANGPTL4 during the course of TGF-β-induced differentiation reduced the mRNA levels of aggrecan and type II collagen, although it increased those of MMP1 and MMP13. Accordingly, deposition of aggrecan and total collagens was diminished, whereas release of MMP1 and MMP13 was increased. Conversely, transfection of MSCs with an siRNA targeting ANGPTL4 prior to induction of chondrogenesis increased expression of type II collagen and aggrecan, whereas it repressed that of MMP1, MMP3, and MMP13. A neutralizing antibody against integrin αVβ5, a known receptor for ANGPTL4, mimicked some of the effects observed after siRNA-mediated ANGPTL4 silencing. Our data provide evidence that ANGPTL4 promotes cartilage matrix remodeling by inhibiting expression of its two key components and by up-regulating the level of certain MMPs.
Fichier principal
Vignette du fichier
IRMB 16_p32_Involvement of Angiopoietin-like 4 in Matrix Remodeling_zbc8402.pdf (3.25 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03116030 , version 1 (20-01-2021)

Licence

Paternité - Pas de modifications

Identifiants

Citer

Marc Mathieu, Mathieu Iampietro, Paul Chuchana, David Guérit, Farida Djouad, et al.. Involvement of Angiopoietin-like 4 in Matrix Remodeling during Chondrogenic Differentiation of Mesenchymal Stem Cells. Journal of Biological Chemistry, 2014, 289 (12), pp.8402-8412. ⟨10.1074/jbc.M113.539825⟩. ⟨hal-03116030⟩
14 Consultations
31 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More